Use of supportive measures to improve outcome and decrease toxicity in docetaxel-based antiangiogenesis combinations.

Authors

null

Fatima H. Karzai

Medical Oncology Branch, National Cancer Institute, Bethesda, MD

Fatima H. Karzai , Bamidele Adesunloye , Yangmin M. Ning , Xuan Huang , Ravi Amrit Madan , James L. Gulley , Andrea Borghese Apolo , Melony A. Beatson , Anna Couvillon , Paul Kluetz , Nancy Harold , Howard L. Parnes , Seth Steinberg , Philip M. Arlen , John Joseph Wright , Clara Chen , Jane Trepel , Nancy Ann Dawson , William Douglas Figg , William L. Dahut

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer

Clinical Trial Registration Number

NCT00942578

Citation

J Clin Oncol 31, 2013 (suppl 6; abstr 128)

DOI

10.1200/jco.2013.31.6_suppl.128

Abstract #

128

Poster Bd #

H11

Abstract Disclosures

Similar Posters

First Author: Daniel Louis Hertz